PAN-Biotech GmbH

Business Strategies

PAN-Biotech’s core business is the development, production and distribution of a broad variety of innovative biotechnological products all around the cell culture. Our business strategy is to develop new products, services and processes to make cell cultivation in research and industry safer, easier and cheaper. Main business topics are industrial cell culture processes for production and research as well as cell-therapeutic developments in the field of diagnostics and regenerative medicine.

Core Technologies and Services

PAN-Biotech produces products for laboratory and industrial use as well as medical-products and in-vitro-diagnostics. PAN-Biotech is accredited according to ISO 9001 as well as ISO 13485 (medical products and in-vitro-diagnostics)
Key products of PAN-Biotech are :

• Serumfree media for research and industry
• Serum- and proteinfree media (animalfree) for industrial applications
• Specialized serumfree media for stem cell research and regenerative medicine
• Development and optimization of cell-media combinations
• Specialized cells and stem cells
• FCS and special variants
• Standard media

Serumfree cell-media kits are available for the most important cell-types in research and industry. To reduce the consumption of animal-component-products, PAN-Biotech developed are very efficient chemically defined serum-substitute.
An important new product range are serumfree stemcell processings as well as automated cell culture systems for research and industry.

Patents, Licenses, Co-operations

Several process and device patents.

Distribution

Direct marketing in Germany, exclusive distributor partner in the most important markets (Europe, Middle East, Asia, Japan, USA, Canada).